XXII

4.95

4.65% 0.22

Handel nachbörslich: 5.03 0.08 +1.62%

22nd Century Group, Inc. (XXII)

Überblick Nachrichten Preisverlauf Optionskette Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$4.73

Offen:

$4.74

24-Stunden-Volumen:

101.99K

Relative Volume:

1.52

Marktkapitalisierung:

$2.74M

Einnahmen:

$29.78M

Nettoeinkommen (Verlust:

$-39.94M

KGV:

-0.934

EPS:

-5.3

Netto-Cashflow:

$-16.12M

1W Leistung:

-25.32%

1M Leistung:

-62.20%

6M Leistung:

-93.89%

1J Leistung:

-98.83%

1-Tages-Spanne:

$4.61

$5.28

1-Wochen-Bereich:

$3.90

$6.075

52-Wochen-Spanne:

$3.90

$581.85

22nd Century Group, Inc. Stock (XXII) Company Profile

Firmenname

22nd Century Group, Inc.

Sektor

Healthcare (1176)

Branche

Biotechnology (673)

Telefon

716-270-1523

Adresse

8560 Main Street, Williamsville, NY

Mitarbeiter

Twitter

@_xxiicentury

Nächster Verdiensttermin

2024-12-12

Neueste SEC-Einreichungen

XXII's Discussions on Twitter

Vergleichen Sie XXII mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
XXII 22nd Century Group, Inc.	4.95	2.74M	29.78M	-39.94M	-16.12M	-61.91
VRTX Vertex Pharmaceuticals Inc	397.27	102.31B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	701.85	77.13B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	623.82	37.30B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	245.44	31.66B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	113.08	27.11B	3.30B	-501.07M	1.03B	-2.1146

22nd Century Group, Inc. Stock (XXII) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2022-07-21	Eingeleitet	Alliance Global Partners	Buy
2022-06-15	Eingeleitet	Craig Hallum	Buy
2022-03-08	Eingeleitet	ROTH Capital	Buy
2021-07-23	Eingeleitet	Cowen	Outperform
2017-10-16	Bestätigt	Chardan Capital Markets	Buy
2016-08-11	Bestätigt	Chardan Capital Markets	Buy

Alle ansehen

22nd Century Group, Inc. Aktie (XXII) Neueste Nachrichten

Dec 19, 2024

StockNews.com Begins Coverage on 22nd Century Group (NASDAQ:XXII) - MarketBeat

Dec 19, 2024

Dec 18, 2024

22nd Century Group announces reverse stock split - Investing.com

Dec 18, 2024

22nd Century Group announces reverse stock split By Investing.com - Investing.com UK

Dec 18, 2024

Dec 16, 2024

22nd Century : Appoints Leading Plant Biotechnology Expert Dr. Michael Koganov to Board of Directors - Marketscreener.com

Dec 16, 2024

22Nd Century Group Expands VLN Tobacco Growing Program to Support Anticipated Demand of the Company’S Reduced Nicotine Content Cigarettes - Marketscreener.com

Dec 16, 2024

22nd Century Group, Inc. Announces Chief Financial Officer Changes - Marketscreener.com

Dec 16, 2024

XXII Stock Plummets to 52-Week Low of $0.04 Amid Market Turbulence By Investing.com - Investing.com South Africa

Dec 16, 2024

22nd Century : Reduces Debt by Additional $1.5 Million via Payment from GVB Form 8 K - Marketscreener.com

Dec 16, 2024

Dec 15, 2024

22nd Century Group, Inc. announced that it expects to receive $1.6815 million in funding - Marketscreener.com

Dec 15, 2024

Dec 13, 2024

22nd Century Group (NASDAQ:XXII) Stock Quotes, Forecast and News Summary - Benzinga

Dec 13, 2024

22nd Century Applauds FDA Proposal to Mandate Reduced Nicotine Content in Cigarettes - The Kingston Whig-Standard

Dec 12, 2024

Toll Brothers Inc (TOL-N) QuotePress Release - The Globe and Mail

Dec 12, 2024

Dec 07, 2024

22nd Century Group approves reverse stock split By Investing.com - Investing.com Nigeria

Dec 07, 2024

22nd Century Group approves reverse stock split - Investing.com India

Dec 07, 2024

Nov 28, 2024

12 Cannabis Stocks to Buy Now in 2024 - MarketBeat

Nov 28, 2024

Nov 14, 2024

22nd Century Net Loss Widens - Tobacco Reporter

Nov 14, 2024

Nov 13, 2024

22nd Century: Q3 Earnings Snapshot - CT Insider

Nov 13, 2024

XXII stock plunges to 52-week low of $0.09 amid market challenges - Investing.com

Nov 13, 2024